ISSN: 2167-7700
Micro Pistelli
Clinical of Medical Oncology, Marche Polytechnic University, AO Riuniti Hospital -Ancona, Italy
Mirco Pistelli is as of now working at Clinical of Medical Oncology, Marche Polytechnic University, AO Riuniti Hospital - Ancona, Italy. His primary region of research intrigue is Cancer treatment, Chemo Resistance, Electro Chemotherapy, Squamous Cell Carcinoma Tumorigenesis. His examination advantages as reflect in his extensive variety of productions in different national and global diaries. He is having many research subjects among them neoplasm intrusiveness, lymphatic metastasis, bosom neoplasms, organic tumor markers, leucovorin, camptothecin, fluorouracil, adenocarcinoma. He is having numerous distributions which is identified with malignancy. In 2014 he went to an ASCO Annual Meeting about "pretreatment neutrophil to lymphocyte proportion might be a valuable instrument in anticipating survival in early triple-negative bosom tumor patients". His overall experience joins diverse undertakings, responsibilities and participation in different countries for grouped fields of study. His investigation preferences as reflect in his broad assortment of conveyances in various national and worldwide journals. He is associated with ORCID and ORCID is administered by a Board of Directors illustrative of our participation, with wide partner representation. ORCID is upheld by a committed and proficient expert staff.
Cancer therapy, Chemo Resistance, Electro Chemotherapy, Squamous Cell Carcinoma Tumorigenesis